AstraZeneca signs landmark biotechnology deals with KSA
AstraZeneca has signed two landmark agreements on innovation and R&D with Saudi Arabian entities that will support healthcare transformation in the kingdom.
Source: tradearabia.com
Stay updated with breaking news from Riyadh Global Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca has signed two landmark agreements on innovation and R&D with Saudi Arabian entities that will support healthcare transformation in the kingdom.
Riyadh Global Summit for Medical Biotechnology aims to push the boundaries of the existing thinking and practice towards a targeted and sustainable medical biotechnology in the Kingdom of Saudi Arabia.